Start of main content

Neurodegenerative diseases. A 21st Century Challenge

Life and Matter Sciences Series of Conferences February 7, 2017 Madrid

General information

Venue: Fundación Ramón Areces, Vitruvio, 5. 28006. Madrid
Limited capacity

Free registration

Organized by:

Fundación Ramón Areces-Springer Nature

Audio

See more media from this activity

Description
Programme

Nowadays, when life expectancy has increased worldwide, diseases that affect cognitive function, such as Alzheimer's, Parkinson's, or amyotrophic lateral sclerosis (ALS), are increasingly prevalent. Neurodegenerative diseases are a very diverse group of disorders characterized by a progressive failure of the nervous system. In recent years, there has been considerable progress in understanding their molecular and cellular bases. Although the discovery of new targets and biomarkers that allow early diagnosis have opened new lines of research, these diseases continue to be a great challenge for researchers and clinicians.

These challenges include the study of these diseases at the preclinical level, the importance of a patient-centered approach in research, and barriers to the transference of new advances from basic research into the clinic. Society needs to understand these key issues in order to garner its support for research that will translate into future therapies for patients with neurodegenerative diseases.

Tuesday, 7

17:30

Presentation

Raimundo Pérez-Hernández y Torra
Director of the Ramón Areces Foundation. Spain.

Federico Mayor Zaragoza
Chairman of the Scientific Council. Ramón Areces Foundation. Spain.

Soledad Santos Suárez
Editorial Director Spain and Portugal. Springer Healthcare, a Springer Nature business.

17:45

Introduction

Erika Pastrana
Team Manager-Editorial. Nature Communications. New York. USA.

Conferences

18:00

Pathological mechanisms of neurodegenerative diseases. Focus on ALS

Jeffrey D. Rothstein
Director, Robert Packard Center for ALS Research. Johns Hopkins University. School of Medicine. Baltimore. USA.

18:20

Challenges and advances in the treatment of Parkinson's disease

José A. Obeso
HM Hospitales. Centre for Integrative Neuroscience A.C. Center for Networked Biomedical Research on Neurodegenerative Diseases. Institute Carlos III. Madrid. Spain.

18:40